{"id":86995,"date":"2023-11-10T09:39:44","date_gmt":"2023-11-10T04:09:44","guid":{"rendered":"http:\/\/finservwealth.com\/gsk-pharma-reports-higher-than-expected-profit-in-q2-shares-may-rise\/"},"modified":"2023-11-10T09:39:44","modified_gmt":"2023-11-10T04:09:44","slug":"gsk-pharma-reports-higher-than-expected-profit-in-q2-shares-may-rise","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/gsk-pharma-reports-higher-than-expected-profit-in-q2-shares-may-rise\/","title":{"rendered":"GSK Pharma reports higher-than-expected profit in Q2; shares may rise"},"content":{"rendered":"<p> GSK Pharma reported better than expected PAT on lower raw material cost and increased benefit from marketing activities, along with high demand for vaccines.<\/p><div id=\"finse-1983302094\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/gsk-pharma-reports-higher-than-expected-profitq2-shares-may-rise_17319691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0GSK Pharma reported better than expected PAT on lower raw material cost and increased benefit from marketing activities, along with high demand for vaccines. GSK Pharma reported better than expected PAT on lower raw material cost and increased benefit from marketing activities, along with high demand for vaccines.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/gsk-pharma-reports-higher-than-expected-profitq2-shares-may-rise_17319691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> GSK Pharma reported better than expected PAT on lower raw material cost and increased benefit from marketing activities, along with high demand for vaccines.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/gsk-pharma-reports-higher-than-expected-profitq2-shares-may-rise_17319691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0GSK Pharma reported better than expected PAT on lower raw material cost and increased benefit from marketing activities, along with high demand for vaccines. GSK Pharma reported better than expected PAT on lower raw material cost and increased benefit from marketing activities, along with high demand for vaccines.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/gsk-pharma-reports-higher-than-expected-profitq2-shares-may-rise_17319691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> GSK Pharma reported better than expected PAT on lower raw material cost and increased benefit from marketing activities, along with high demand for vaccines.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-86995","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2017\/200x200\/g\/gsk-glaxosmithkline-pharma-medicine_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/86995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=86995"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/86995\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=86995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=86995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=86995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}